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Local Expression of TNFa in Neonatal NOD Mice
Promotes Diabetes by Enhancing Presentation
of Islet Antigens
contrast to the above data, administration of rTNFa to
adult NOD mice protected against diabetes, while anti-
TNFa treatment enhanced disease (Yang et al., 1994).
Similarly, NOD mice that express TNFa in the islets un-
der control of the rat insulin promoter (RIP) fail to develop
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Here, we address the role of TNFa in the islets of
neonatal NOD mice carrying the same RIP-TNFa trans-
gene described previously in C57BL/6 (B6) (Picarella etSummary
al., 1993) and BALB/c mice (McSorley et al., 1997). NOD
mice expressing TNFa in their islets (TNFa-NOD mice)The relationship of inflammation to autoimmunity has
from birth showed dramatically accelerated progressionbeen long observed, but the underlying mechanisms
and penetrance of disease compared to nontransgenicare unclear. Here, we demonstrate that islet-specific
littermates (non-tg). Neonatal expression of TNFa led toexpression of TNFa in neonatal nonobese diabetic
apoptosis of some b cells and an influx of dendritic cellsmice accelerated diabetes. In neonatal transgenic
that process and present islet antigen to islet-specificmice, disease was preceded by apoptosis of some b
T cells. Finally, we offer a mechanism by which TNFacells, upregulation of MHC class I molecules on resid-
may influence the antigen presentation capacity of islet-ual islet cells, and influx and activation of both antigen-
infiltrating cells and promote progression to diabetes.presenting cells bearing MHC±islet peptide complexes
and T cells. Infiltrating dendritic cells/macrophages,
but not B cells, from neonatal islets activated islet- Results
specific T cells in vitro. Thus, inflammation can trigger
autoimmunity by recruiting and activating dendritic Expression of TNFa Is Restricted to the
cells/macrophages to present self-antigens to auto- Pancreas of TNFa-NOD Mice
reactive T cells. Localized expression of TNFa in the islets of adult NOD
mice protects against diabetes development (Grewal et
Introduction al., 1996). We decided to test whether such restricted
expression of TNFa in neonatal NOD mice induced a
Insulin-dependent diabetes mellitus (IDDM) is a T cell± similar outcome or, instead, led to an autoaggressive
mediated autoimmunity in which the insulin-secreting b response toward b cells. Islet-specific expression of
cells of the islets of Langerhans are selectively de- TNFa in neonatal NOD mice was achieved by backcross-
stroyed (Tisch and McDevitt, 1996). The nonobese dia- ing the previously described RIP-TNFa mice, from the
betic (NOD) mouse is a model for IDDM, since its genet- B6 background (Picarella et al., 1993) to NOD mice
ics and pathology closely resemble that of humans (TNFa-NOD). Using tg-specific primers (Figure 1a), semi-
(Delovitch and Singh, 1997). Studies in NOD mice have quantitative RT±PCR analysis of total RNA prepared
demonstrated that, before destruction of b cells, islets from 3-day-old TNFa-NOD mice demonstrated that
become rapidly infiltrated with myeloid and lymphoid transgene-encoded TNFa was restricted to the pan-
cells (Jansen et al., 1993, 1994; Leenen et al., 1994), and creas of neonatal TNFa-NOD mice (Figure 1b) and could
this insulitis is crucial for the development of diabetes not be detected in the thymus even when the concentra-
(Katz et al., 1993a; Serreze et al., 1997). tion of cDNA was increased 16-fold, with respect to
Inflammation and inflammatory cytokines induced by, pancreatic cDNA levels (Figure 1b, lower panel). No
for instance, infection, have been implicated in autoim- TNFa expression was detected in any other tissue as
munity (Ehl et al., 1998), as well as insulitis, destruction reported previously (Picarella et al., 1993). Thus, TNFa-
of b cells, (Picarella et al., 1993; Chakrabarti et al., 1996; NOD mice express TNFa RNA as neonates, and this
Wang et al., 1997), and thereby disease progression in expression is restricted to the local environment of
IDDM. Tumor necrosis factor a (TNFa) is an inflammatory the pancreas. Further, we cultured islets of RIP-TNFa
cytokine secreted principally by macrophages, but also transgene positive and negative mice in vivo and deter-
by activated CD41 T cells and other cell types upon mined the level of TNFa secreted (Grewal et al., 1996).
stimulation (Vassalli, 1992). Interest in TNFa as a media- Only low, but detectable levels of TNFa in transgene
tor of IDDM is based on several observations: TNFa positives were seen (,2 pg/ml); TNFa was undetectable
mRNA is produced in situ in inflamed islets in NOD in blood.
mice (Held et al., 1990); treatment of neonatal NOD with Previous work has suggested that TNFa may influence
recombinant TNFa (rTNFa) accelerated diabetes; and T cell development in the thymus, particularly in the
neutralizing anti-TNFa monoclonal antibodies protected stage III CD25hi CD44lo population, which may lead to
against both insulitis and disease (Yang et al., 1994). In an increase in autoreactive T cells in the periphery (Vella
et al., 1995; Cope et al., 1997; Ettinger et al., 1998).
However, FACS analysis of thymi derived from 3-week-³ To whom correspondence should be addressed (e-mail: richard.
flavell@qm.yale.edu). old non-tg (n 5 8) and TNFa-NOD mice (n 5 8) yielded
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Figure 1. Expression of TNFa Is Restricted
to the Pancreas of TNFa-NOD Mice
(a) Diagrammatic representation of the RIP-
TNFa construct. The construct encodes the
genomic sequence for murine TNFa down-
stream from the rat insulin promoter type II
(RIPII). Major restriction sites are shown. Lo-
cations of PCR 59 and 39 primers and the HIII-
HIII probe used for the detection of tg TNFa
RNA are indicated.
(b) TNFa expression is restricted to pancreas.
(Upper panel) cDNA was prepared from the
thymus or pancreas of TNFa-NOD mice, nor-
malized by competitive HPRT RT-PCR, then
serially diluted 4-fold from a starting dilution
of 1:10. TNFa cDNA was measured by RT-
PCR and detected with a TNFa specific
probe. (Lower panel) Thymic cDNA was in-
creased 16-fold in concentration with respect
to pancreatic cDNA levels, and TNFa mRNA
was measured as before.
(c) Diabetes onset and incidence in N6 gener-
ation TNFa-NOD mice or non-tg littermates.
Closed circles, pooled male and female
TNFa-NOD mice (n 5 21); open circles, fe-
male non-tg (n 5 12); open squares, male
non-tg (n 5 12).
(d) N8 generation TNFa-NOD.scid/scid mice
do not develop diabetes. Open squares, wild-
type TNFa-NOD mice (n 5 8); closed circles,
TNFa-NOD.scid/1 mice (n 5 12); open cir-
cles, TNFa-NOD.scid/scid mice (n 5 10).
no differences in T cell development, including stage III was not due to the presence of B6 alleles at the reported
aid (aggressive insulin-dependent diabetes) loci on(data not shown). Similar analysis of bone marrow and
peripheral T and B cells from non-tg (n 5 5) and TNFa- chromosomes 7 and 1 (Gonzalez et al., 1997), since mice
from N6 generation backcross contained NOD alleles atNOD mice (n 5 5) revealed no differences in cell numbers
or percentages of any populations (data not shown). these positions, as well as all other known idd loci
(Wicker et al., 1995). Further, the time of onset and inci-
dence of disease in TNFa-NOD mice stayed constantAccelerated Onset of Diabetes
in TNFa-NOD Mice in subsequent backcrosses (through N12).
Unlike previous reports (Grewal et al., 1996), islet-spe-
cific neonatal expression of TNFa accelerated the onset TNFa in the Islets of Neonatal NOD.scid/scid
Mice Does Not Lead to Diabetesand penetrance of diabetes in TNFa-NOD mice com-
pared to non-tg littermates. By the fifth generation back- To address whether accelerated onset of diabetes in
TNFa-NOD mice resulted from toxicity of TNFa for bcross (N6), diabetes was detectable as early as 9 weeks
with 100% disease by 14 weeks (Figure 1c) in both male cells (Cetkovic-Cvrlje and Eizirik, 1994), we crossed
TNFa-NOD mice (N7) to NOD.scid mice, which do notand female TNFa-NOD mice. Thus, islet-specific expres-
sion of TNFa overcame the sex bias of diabetes develop- develop diabetes (Prochazka et al., 1992). Both wild-
type TNFa-NOD mice and TNFa-NOD mice heterozy-ment in NOD mice. In contrast, only female non-tg lit-
termates developed disease, starting at 13 weeks, with gous for the scid mutation developed diabetes with simi-
lar kinetics and penetrance (Figure 1d). In contrast,60% of females diabetic by week 25.
Diabetes in TNFa-NOD mice was due to destruction TNFa-NOD mice homozygous for the scid mutation re-
mained normoglycemic over a 30 week observation pe-of islet b cells and not inhibition of insulin-receptor sig-
naling (Uysal et al., 1997), since a decrease in the number riod, irrespective of their sex. Thus, toxicity alone, in
the absence of an intact immune system, is unlikely toof insulin-secreting b cells occurred as early as day (d)42
(Figure 2a). By d54, few intact b cells remained. account for increased incidence of diabetes in TNFa-
NOD mice.This accelerated onset of disease in TNFa-NOD mice
TNFa Promotes Presentation of Islet Antigen
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Figure 2. TNFa-NOD Mice Exhibit a Rapid
Destructive Insulitis
(a) Decrease in insulin-producing b cells in
pancreas of TNFa-NOD mice with respect to
age. Pancreatic sections from d15, d42, and
d54 TNFa-NOD mice were stained for insulin
production. The figure is representative of
five individual mice examined for each group
at ages shown.
(b and c) Graphical representation of the ki-
netics and penetrance of insulitis in TNFa-
NOD mice (b) compared to non-tg littermates
(c). Fifty individual islets were scored for in-
sulitis at the times indicated. Mild peri-insul-
itis: ,50% of islet infiltrated, intact b cells;
insulitis: .50% of islet infiltrated, some b cell
damage; destructive insulitis: .50% of islet
infiltrated, few intact b cells present.
(d) Correlation between b cell damage and
anti-GAD T cell responses in TNFa-NOD mice.
Splenocytes (5 3 105) from d42 TNFa-NOD
mice, or non-tg littermates, were cultured
with either GAD at indicated values (mg/ml) or
2.5 mg/ml ConA. Data represent incorporation
of [3H]thymidine following a 4 day culture.
Control values of splenocytes cultured in me-
dium were ,300 cpm.
Neonatal Expression of TNFa Results in More Apoptosis of Neonatal Islets in TNFa-NOD
Mice Precedes InsulitisRapid and Severe Insulitis in NOD Mice
Insulitis precedes diabetes in NOD mice (Katz et al., The rapid infiltration of islets in d13±d15 TNFa-NOD mice
suggested that physiological (or pathological) changes1993a; Serreze et al., 1997). To determine the time
course of insulitis, we analyzed non-tg and TNFa-NOD had occurred to either the b cells, or to the surrounding
tissue, that provided a trigger for initiation of insulitis.mice, and islets were scored for insulitis (Figures 2b and
2c). As early as d10, 20% of islets in TNFa-NOD mice Changes that could induce insulitis are islet antigen lib-
eration, following damage to b cells (Shimizu et al.,had detectable peri-insulitis (Figure 2b). The number of
islets infiltrated increased rapidly over the next 5 days, 1995); upregulation of MHC class I molecules on b cells
(Kay et al., 1996); and activation of the endotheliumwith only 30% of islets free of infiltrating cells, and 10%
having invasive insulitis. By d28 b cell destruction was (Henseleit et al., 1995). Since apoptosis is implicated in
b cell death (O'Brien et al., 1997; Stassi et al., 1997) andapparent in 10% of islets in TNFa-NOD mice and rose
to over 60% by d54. This high level of b cell destruction TNFa is an efficient inducer of apoptosis (Cleveland and
Ihle, 1995), we assessed whether apoptosis of b cellsat d54 correlated with the first detectable diabetes.
The rapid kinetics and penetrance of insulitis in TNFa- occurred prior to insulitis. Indeed, apoptotic cells were
identified in TUNEL-labeled pancreatic sections in d7±NOD mice contrasted sharply with non-tg mice, where
insulitis was slowly progressive and rarely detectable d10 TNFa-NOD mice, but not non-tg mice (Figure 3a).
Dual staining for apoptosis and insulin confirmed thatprior to d28 (Figure 2c). This gradual rate of insulitis
leading to diabetes at 13±25 weeks agrees with prior the apoptotic cells were b cells (data not shown). In 5
out of 20 islets examined, between 4±6 apoptotic cells/observations in NOD mice (AndreÂ et al., 1996).
The severity of insulitis and the presence of damaged islet were counted at this time point in TNFa-NOD mice;
however, no insulitis was seen in these islets. A similarb cells also correlated with increased responses to glu-
tamic acid decarboxylase (GAD), an important autoanti- but later pattern of apoptosis of b cells in NOD mice
has been described elsewhere (O'Brien et al., 1997).gen in IDDM (Kaufman et al., 1993; Tisch et al., 1993).
Thus, at d42 anti-GAD T cell responses were seen in Immunohistochemical studies also revealed other
changes in d7±d10 TNFa-NOD mice. Both MHC class Ithe spleens of TNFa-NOD mice but not non-tg mice
(Figure 2d). (Figure 3a) as well as VCAM-1 (not shown) expression
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Figure 3. Histological Changes in Neonatal TNFa-NOD Mice
(a) Apoptosis and upregulation of MHC class I precedes insulitis in TNFa-NOD mice. Pancreata from d10 TNFa-NOD mice or non-tg littermates
were examined for the presence of apoptotic cells by TUNEL staining. MHC class I expression was detected with Histomark Red. (Bottom
panels) Y-AE staining. Pancreatic sections from 2-week-old RIP-I-E (left) and RIP-I-E 3 RIP-TNFa-B6 (right) were stained with Y-AE and MHC
class II I-E.
(b) Dendritic cells in islets of d18 TNFa-NOD mice upregulate CD86. Representative flow cytometric analysis of CD86 expression on CD11c1
dendritic cells present in the islets, or spleen, of TNFa-NOD mice. Cells were triple-stained with CD45, CD11c, and CD86, and the percentage
of cells expressing high levels of CD86 (right panels) was measured in CD451/ CD11c1 populations (left panels).
were upregulated in the pancreas of TNFa-NOD but or CD11b1, F4/802) and Mφ (CD11b1 F4/801) increased
by d15 and were found close to CD41 T cells (Figureswere not detected in non-tg mice.
4a and 4b). B cells were seen by d15 (Figure 4c) located
in areas distinct from both DCs and CD41 T cells. AtNeonatal Islets from TNFa-NOD Mice Show
Sequential Infiltration with Dendritic Cells, this age, the first CD81 T cells were detected (Figure
4d) also close to DCs and CD41 T cells. This early infiltra-B Cells, and T Cells
In NOD mice the first cells to infiltrate the islets are tion was further supported by flow cytometric analysis
of cells isolated from the islets of neonatal TNFa-NODdendritic cells/macrophages (DC/Mφ), followed by B and
T cells (Rosmalen et al., 1997; DahleÂ n et al., 1998). Cells mice (Table 1). Interestingly, there was upregulation of
activation markers on CD41 T cells infiltrating the isletsinfiltrating the pancreas from TNFa-NOD mice of various
ages were examined by immunohistochemistry (Figures between d18±d22. CD11c1 DCs also showed evidence
of activation since they upregulated MHC class II (data4a±4l). Examination of the few islets with peri-insulitis
from d10 TNFa-NOD mice revealed that DCs and Mφ not shown) and CD86 (Figure 3b) molecules (Pierre et
al., 1997; Banchereau and Steinman, 1998).were the first cells to infiltrate (data not shown), with
neither B cells nor T cells detected. DCs (CD11c1 and/ By d28±d42, CD11c1 DCs increased in number (Figure
TNFa Promotes Presentation of Islet Antigen
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Figure 4. Histological Examination of the Islet-Infiltrating Cells from TNFa-NOD Mice
Pancreata from d15 (a±d), d42 (e±h), and d54 (i±l) TNFa-NOD mice were examined for the presence of CD11c1 (a, e, and i), CDllb1 (b, f, and
j), B2201 (c, g, and k), CD81 (d, h, and l), and CD41 (a±l) cells. Purple, CD11c1, CD11b1, B2201, and CD81 cells; brown, CD41 cells.
4e) and were in a more central islet location. CD11b1 cellular composition, islet location, and invasiveness,
resembled that of TNFa-NOD mice but developed muchcell numbers did not increase (Figure 4f), and of the
CD11b1 cells present, only those at the outer perimeter later. Thus, in non-tg mice, the first signs of infiltration
occurred at 28±42 days of age, the principal cells de-of the islet coexpressed F4/80. B cell numbers increased
between d28±d42 and were grouped near the islet pe- tected being CD11c1 DCs, CD11b1, F4/801 Mφ, and a
few CD41 T cells. B cells entered after DCs, with CD81riphery (Figure 4g). In fact, from this age onward, B cells
always outnumbered other infiltrating cells. CD41 T cells T cells entering last. The earliest infiltrating cells were
located at the periphery and only assumed a centralremained at the perimeter of the islet and stayed there
throughout the development of diabetes (Figures 4i±4l). islet location when they increased in numbers (data not
shown).In contrast, CD81 T cell numbers rose and were dis-
persed throughout the islet (Figure 4h).
At d54±d70, when the first signs of diabetes were Early Expression of TNFa in NOD Islets
Helps Potentiate Activation ofdetectable, CD11c1 cells were still present (Figure 4i)
and found in similar locations as CD81 T cells (compare Islet-Specific T Cells
The increase in size and activation status of CD41 TFigures 4i and 4l). No CD11b1 cells remained (Figure
4j), which also correlated with an inability to detect F4/ cells in neonatal islets of TNFa-NOD mice, and the fact
CD41 T cells were located in areas close to APCs, sug-801 cells. B cells by this time occupied .50% of the
islet (Figure 4l). gested that infiltrating APC were presenting antigen in
situ to CD41 T cells.The pattern of insulitis in non-tg mice, in terms of
Immunity
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the presence, or absence, of various concentrations ofTable 1. FACS Analysis of Islet-Infiltrating Cells
murine rTNFa. NOD.scid islets were used as an antigen
Percentage of Total Islet Cells source. Although addition of rTNFa resulted in slight
enhancement (S.I. 2.8, Figure 5c) of the response byCell Type 18 Days Old 20 Days Old 22 Days Old
TcR-Tg cells, this was significantly less than the re-T cells
sponse generated by islet-APC described above. Thus,CD8 0 6.7 7.2
mitogenic activation of TcR-tg T cells by TNFa is unlikelyCD4 11.8 23.1 28.4
Unactivated ND 66.1 48.9 to contribute to enhancement in response of TcR-tg T
Activated ND 15.3 39.1 cells to their cognate antigen.
B cells 6.9 27.7 23.2
CD11c 10.4 15.3 15.7 Neonatal Islets from TNFa-NOD Mice Contain
CD11b 10.8 15.9 15.3
Antigen-Loaded DC/Mφ and StimulateF4/80 2 ND ND
Islet-Specific CD41 TcR-tg T Cells
Cells were extracted from the islets of TNFa-NOD mice at the ages The fact that TNFa recruited APCs to islets, which then
indicated and analyzed by FACS. Percentage of activated and unac-
activated CD41 T cells, predicted that these APCs ac-tivated cells was based on cell size (forward scatter) and expression
quired antigen from b cells, processed this into MHC±of CD44, CD45RB, CD62L, and CD69. ND, not determined.
peptide complexes, and presented these to T cells. To
demonstrate the ability of TNFa to generate these com-
plexes in vivo, we used an antibody that detects MHC±
To test this, we extracted the cells from islets of d15 peptide complexes directly. Since no such antibody ex-
TNFa-NOD mice and assayed their capacity to stimulate ists for the NOD mouse, we used the Y-AE antibody
BDC2.5 TcR NOD islet-specific CD41 T cells (TcR-tg T (Murphy et al., 1989), which detects I-Ab containing a
cells) (Katz et al., 1993b). LN cells from the same mice specific fragment of I-Ea. RIP-TNFa-B6 mice (Picarella
were similarly used to stimulate TcR-tg T cells. TcR-tg et al., 1993) were crossed with RIP-IE tg mice, which
express the Ea molecule specifically in b cells (Lo et al.,T cells did not respond to LN cells as stimulators from
1988); if the above hypothesis is correct, TNF producedeither TNFa-NOD mice or non-tg mice (Figure 5a). In
in the islet should recruit APCs that will pick up Eacontrast, cells extracted from the islets of d15 TNFa-
antigen from islet cells and process and present this onNOD mice resulted in a significant 40-fold increase in
I-Ab. RIP-IE/RIP-TNFa double tg mice contained isletthe response. Islet preparations from non-tg mice dem-
cells staining strongly for the Y-AE epitope, whereasonstrated no detectable ability to present antigen to
control RIP-IE mice did not; both strains of mice stainedTcR-tg T cells as expected, since at this age, non-tg
prominently for the I-E molecule itself (Figure 3a).mice have no infiltrating APC in their islets. ConA added
To determine whether endogenous MHC±peptideto TcR-tg T cells did not induce any proliferation, indicat-
complexes such as the above were responsible for theing the purity of the T cell population. The ability of islet
T cell activation mediated by islet cells in TNFa-NOD tginfiltrating APC to present antigen to TcR-tg T cells was
mice, we recovered APCs from the islets of 18-day-oldalso found in d18, d20, and d22 TNFa-NOD mice. At
TNFa-NOD mice by cell sorting to eliminate b cells asnone of the time points selected were we able to detect
a source of antigen in the presentation assay. APCsislet antigen presentation capacity in the LN of either
were further separated into DC/Mφ or B cells. FACSnon-tg or TNFa-NOD mice (data not shown). This sug-
analysis of sorted populations demonstrated that ,5%gests that trafficking of APC bearing islet antigen to the
of the DC/Mφ fraction contained B cells and ,2% oflocal draining LNs may not occur at appreciable levels
the B cells fraction contained contaminating DC/Mφ.in TNFa-NOD mice, at least at the times analyzed.
Both fractions had ,2% contaminating islet cells.These islet-infiltrating APC from d15 TNFa-NOD mice
B cells did not stimulate TcR-tg T cells in the absencealso activated purified CD41 T cells from prediabetic
of exogenous islet antigen (Figure 6, left panel) but couldNOD mice that were specific for a broad range of islet
activate responder cells if they were provided with suffi-antigens (Figure 5b), whereas LN cells from these mice
cient islet antigen (right panel). In contrast, the DC/Mφscould not. Further, islet-infiltrating APC from d15 TNFa-
enhanced the response of TcR-tg T cells 42-fold aboveNOD mice efficiently presented autoantigen GAD to the
background levels in the absence of exogenous isletsame purified CD41 T cells (Figure 5b). Supernatants
antigen. To confirm that this enhanced response re-
from these GAD-stimulated cells contained IFNg, but
flected peptide complexes already on the surface of
not IL-4 (data not shown).
DC/Mφs and was not due to presentation of the minor
Thus, APC infiltrating the islets of neonatal TNFa-NOD levels of islet antigen remaining in this sorted fraction,
mice were able to present islet antigen to both a biased, we cultured DC/Mφ with TcR-tg T cells in the presence
and nonbiased, T cell repertoire and induce a Th1-based of the antigen processing inhibitor leupeptin. Even with
response. leupeptin, islet-derived DC/Mφ from neonatal TNFa-
NOD mice enhanced the response of TcR-tg T cell 20-
Exogenous TNFa Is Not Mitogenic fold above background levels. The loading of antigen did
for Islet-Specific CD41 T Cells not occur during isolation of the APC, since leupeptin-
The above data suggested that the islets of neonatal resistant presentation occurred when irradiated whole-
TNFa-NOD mice contained potent APC. However, it re- islet suspensions from TNFa-NOD mice were used (data
mained possible that endogenous production of TNFa not shown). These findings suggest two major points.
by b cells in vitro had a mitogenic effect on the responder First, DC/Mφ infiltrating neonatal islets are not only ca-
cells. We tested this by culturing splenic APC from pable of processing and presenting exogenous islet an-
tigen, but they also contain islet-derived peptides on6-week-old NOD mice with purified TcR-tg T cells in
TNFa Promotes Presentation of Islet Antigen
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Figure 5. Islet-Infiltrating APC Can Present Islet Antigen to Islet-Specific T Cells
Irradiated pancreatic lymph node cells (LN) (5 3 105), or 1.5 3 104 irradiated islet-derived cells, were cultured with either 105 purified BDC2.5
TcR-tg NOD CD41 T cells (a) or purified CD41 T cells from prediabetic NOD mice (b), and proliferation after 4 days was determined by
incorporation of [3H]thymidine. Alternatively, 1.5 3 104 irradiated islet-derived cells were cultured with purified CD41 T cells in the presence
of 10 mg/ml GAD and proliferation measured as above. Values represent the mean 6 standard deviation of triplicate cultures. Stimulation
indices, calculated as percentage increase in CD41 T cell response compared to background levels of CD41 T cells alone, are shown above
each bar. As controls for purity, CD41 T cells were cultured with 2.5 mg/ml ConA, and proliferation was determined as above. (c) Exogenous
rTNFa does not enhance presentation of islet antigen to TcR-tg T cells. Purified BDC2.5 TcR-tg T cells (105) were cultured with 5 3 105
irradiated (3000 rads) splenocytes from prediabetic NOD mice and 1.5 3 104 irradiated (4000 rads) islet cells from NOD-scid mice in the
presence or absence of rTNFa. Proliferation was calculated after 4 days, as above. Background cpm for TcR-tg T cells cultured with rTNFa
alone were ,300 cpm for all concentrations of rTNFa.
their surface. Second, B cells in neonatal islets from the islets. Subsequent functional assays demonstrated
that the DC/Mφ fraction contained MHC class II±isletTNFa-NOD mice can process and present islet antigen
to islet-specific T cells but do not themselves have islet antigen complexes and could present these in situ in
islets of neonatal TNFa-NOD mice to CD41 T cells. Thus,antigen on their surface at levels sufficient to stimulate
TcR-tg T cells. rapid acceleration to diabetes in TNFa-NOD mice de-
rives from the ability of TNFa to enhance the maturation
and efficacy of DCs to prime the immune system to isletDiscussion
antigen.
Localized expression of TNFa in the islets of neonatal
NOD mice accelerated progression to diabetes; the pen-
etrance of disease was acute for both male and female How Can Localized Production of TNFa in
Neonatal Islets of NOD Mice Acceleratemice and rose as the mice became increasingly homozy-
gous for NOD disease susceptibility alleles. Rapid pro- Diabetes Progression?
There are several possible scenarios that could explaingression to diabetes correlated with an earlier, more
destructive insulitis than in NOD mice and was preceded how TNFa might accelerate IDDM. First, TNFa may inter-
fere with the deletion of self-reactive T cells in the thy-by apoptosis of some b cells. Histological analysis re-
vealed that activated APC are the first cells to infiltrate mus (Vella et al., 1995; Cope et al., 1997) increasing the
Immunity
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Figure 6. Islet-Infiltrating DC/Mφ, Not B Cells,
Contain Islet Antigen on Their Surface and
Can Stimulate CD41 TcR-tg T Cells
(Left panel) Mitomycin c±treated B cells (3 3
104) or 5 3 103 irradiated DC/Mφ, enriched
from the islets of d18 TNFa-NOD mice, were
cultured with 105 purified CD41 TcR-tg T cells.
Alternatively, the DC/Mφ fraction was incu-
bated with TcR-tg T cells in the presence of
2 mM leupeptin to inhibit presentation of any
contaminating islet antigen in this sorted
population.
(Right panel) Mitomycin c±treated B cells (3 3
104) were incubated with 105 purified CD41
TcR-tg T cells in the presence or absence of
1.5 3 104 irradiated islet cells from NOD.scid
mice. Proliferation was determined after a
4 day culture as in Figure 5. TcR-tg T cells
cultured with 2 mM leupeptin were ,150 cpm.
precursor frequency of autoreactive cells in the periph- the islets of d15±d18 TNFa-NOD mice and can efficiently
present islet antigen to both high-frequency islet-reac-ery. Second, TNFa may be directly toxic for b cells in
vivo. Third, early expression of TNFa may promote rapid tive T cell repertoire (BDC2.5 TcR-tg T cells) as well as
a diverse T cell repertoire (prediabetic NOD splenic Tand more aggressive infiltration of the islets. Fourth,
TNFa may have a direct effect on the expansion and cells). TNFa is unlikely to be a T cell mitogen, since
exogenous TNFa did not increase the response of theactivation of islet-specific T cells recruited to the pan-
creas. Finally, TNFa may selectively recruit distinct pop- islet-specific T cells to islet antigen, even over a very
broad dose range of TNFa (0.005±50 ng/ml).ulations of APC to the pancreas that either themselves
are stimulators of autoaggressive T cells or can mature We have asked whether in situ production of TNFa in
the islets of TNFa-NOD mice exerts a direct effect on afollowing exposure to TNFa in situ.
The first two possibilities seem unlikely. First, we did particular group of APCs, via their selective recruitment
and/or activation. Three major populations of APC infil-not find any transcripts for transgenically encoded TNFa
in the thymus, reported for other RIP transgenes (Smith trated the islets of TNFa-NOD mice: DCs, Mφ, and B
cells. F4/801 Mφ were present in small numbers at theet al., 1997), nor were there any differences between
TNFa-NOD mice and non-tg in T cell populations in the initial stage of insulitis, at the perimeter of the islet, but
decreased thereafter. CD11c1 cells (6 CD11b) precededthymus or periphery. However, these findings cannot
formally exclude more elaborate hypotheses, such as B cells into the islets of TNFa-NOD mice (though by only
a few days), detectable as early as d10 (data not shown).low levels of TNFa affecting thymic selection.
Toxicity of TNFa for b cells alone is also unlikely to Nevertheless, B cell numbers increased more markedly
than DCs in neonatal islets of TNFa-NOD mice. Thisaccount for accelerated diabetes in TNFa-NOD mice,
since the same transgene in both the B6 background would suggest that TNFa does not selectively recruit
one APC over the other and supports observations that(Picarella et al., 1993) and the BALB/c background
(McSorley et al., 1997) and the late expressing TNFa the inflammatory property of TNFa enhances both DC
(Roake et al., 1995) and naive/memory B cell (Corcionetransgene (Grewal et al., 1996) do not induce diabetes.
This was further supported by the observation that et al., 1997) migration.
If the accelerated incidence of diabetes does not re-TNFa-NOD mice crossed to NOD.scid mice did not pro-
gress to diabetes. late to the recruitment by TNFa of a particular APC, then
does the cytokine enhance the presentation capacity ofIn contrast, considerable support is provided for the
antigen presentation model. Apoptosis of some b cells a particular infiltrating APC? The ability of APC to acti-
vate T cells is related in part to the level of MHC±peptideand, at the same time, upregulation of MHC class I mole-
cules on intact b cells occurred prior to insulitis in d7± complexes and costimulatory molecules (CD80 and
CD86) present on the surface of the APC (Cella et al.,d10 TNFa-NOD mice. The relationship between apopto-
sis and diabetes in NOD was established in several 1997). In IDDM, the importance of costimulatory mole-
cules in progression to diabetes has been demonstratedmodels (Chervonsky et al., 1997; Itoh et al., 1997).
Though principally believed to function as an effector by tg expression of CD80 (Guerder et al., 1994; Harlan
et al., 1994; Wong et al., 1995), or CD86 moleculesmechanism in b cell destruction at the end stage of
IDDM, more recent reports have demonstrated that apo- (Guerder et al., 1998) on b cells, or neutralizing anti-CD86
antibodies (Herold et al., 1997). Although upregulation ofptosis occurs, in NOD mice, immediately prior to insulitis
(O'Brien et al., 1997). costimulatory CD86 and MHC class II molecules was
seen to occur on both infiltrating DC/Mφ and B cells,Following apoptosis of b cells we believe that TNFa
recruits APCs to the islets and mediates their activation; only DC/Mφ efficiently presented islet antigen to re-
sponder cells in vitro.they then activate infiltrating T cells. This is based on
two findings. First, CD41 T cells in the islets of d15±d21 This ability to activate islet-specific T cells was a prop-
erty of freshly isolated islet DC/Mφs, even in the ab-TNFa-NOD mice upregulated activation markers during
this time period. Second, infiltrating APC are present in sence of exogenous islet antigen. Addition of exogenous
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islet antigen to these DC/Mφs increased further the level mice except that the two phases described are more
defined and synchronous in the tg model. Although, weof T cell activation (.4003, data not shown). Thus, en-
hanced presentation of islet antigen in vitro suggests cannot exclude that the mechanism(s) responsible for
diabetes progression in NOD mice is distinct from thatboth mature and immature DCs exist in the islets of d18
TNFa-NOD mice. The presence of both types of DCs in in TNFa-NOD mice, our study provides a good model
to evaluate this further.the islets at this neonatal stage suggests that production
of TNFa by tg b cells may promote the maturation of In conclusion, we believe that TNFa exacerbates
IDDM in NOD mice in the same way that infection andDCs (and thereby their T cell activation capabilities) in
situ (Reid et al., 1992; Banchereau and Steinman, 1998). chronic inflammation may precipitate autoimmunity in
other spontaneous models and human autoimmunity.This is also indicated by the upregulation of CD86 on
DCs between d15±d21. Alternatively, TNFa may help We propose that inflammatory cytokines recruit and ac-
tivate DC/Mφ precursors to present autoantigens torecruit both mature and immature DCs to the islets. This
hypothesis that infiltrating DC/Mφs are the major APCs autoreactive T cells present in the repertoire of autoim-
mune predisposed animals and people. These T cellsto present islet antigen in neonatal TNFa-NOD mice
is further supported by the recent evidence that DCs then trigger the effector pathways that lead to tissue
destruction and morbidity.efficiently acquire antigen from apoptotic cells (Albert
et al., 1998). Whether the b cell apoptosis is critical
Experimental Proceduresin the activation of islet-specific T cells, by providing
infiltrating DCs with islet antigen, is intriguing.
MiceDo APCs, recruited to the islets of neonatal TNFa-
RIP-TNFa mice on the B6 background (Picarella et al., 1993) wereNOD mice, promote the activation of autoreactive CD41
backcrossed to NOD mice for at least five generations. Mice con-
and/or CD81 T cells? Both CD41 and CD81 T cells are taining the TNFa transgene and increasing homozygosity for NOD
important in IDDM (Miller et al., 1988; Peterson and Has- alleles at the 15 idd loci (Wicker et al., 1995) were selected for
backcrossing.kins, 1996; Wong et al., 1996). In TNFa-NOD mice, al-
TNFa-NOD.scid/scid mice were obtained by crossing TNFa-NODthough CD41 T cells preceded CD81 T cells into the
mice (N7) with NOD.scid mice, followed by intercrossing.islets, increased numbers of CD81 T cells correlated
All NOD mice were bred and maintained in our animal facility, thewith the earliest evidence of b cell destruction and the
disease incidence being 80% for females and 65% for males by 30
presence of anti-GAD T cell responses in the spleens weeks of age.
of TNFa-NOD mice. Furthermore, CD81 T cells were BDC2.5 TcR-tg mice were provided by J. D. Katz, Washington
University, St. Louis, MO.dispersed throughout the islet where they may encoun-
ter b cells, whereas CD41 T cells were not, suggesting
Preparation of RNA and RT±PCRthat the CD81 T cell may be the principal effector cell
RNA was prepared from all tissues using TRIzol (GIBCO BRL, Lifefor b cell destruction in TNFa-NOD mice, with CD41 T
Technologies Inc., Gaithersburg, MD). cDNA was synthesized by
cells functioning to activate the CD81 T cells (Bennet et standard methods, and tg TNFa was amplified by PCR using a
al., 1998; Ridge et al., 1998). primer from RIP II (59→39: ATT TGA GGG ACG CTG TGG GCT CTT)
It is unclear at this time why early expression of TNFa and a primer from exon II of the murine TNFa gene (59→39: TGT
GAG GGT CTG GGC CAT AGA ACT GAT GAG; Figure 1a). PCRin NOD islets (this report) leads to early disease onset
conditions were 928C, 1 min; 558C, 1 min; and 728C, 1 min in thewhile late expression (Grewal et al., 1996) protects. The
presence of 2.5 mM MgCl2. Competitive HPRT (hypoxanthine phos-mice described in this report are homozygous for all
phoribosyl transferase) PCR was performed as described (Reiner
known NOD alleles, and the late expressors (Grewal et et al., 1993).
al., 1996) were made directly in NOD, suggesting that
the site of insertion of the tg is unlikely to be involved. Pancreatic Histology
Further studies with TCR-tg systems will be required to Pancreata were processed for immunohistochemistry by fixing in
1% paraformaldehyde and passage through sucrose gradients be-elucidate the differences.
fore freezing (Picarella et al., 1993). Insulin was detected using an
alkaline phosphatase (Biogenex, San Ramon, CA) and BCIP/NBT
substrate kit (Zymed, San Francisco, CA). H2-Kd, CD11c, CD11b,TNFa-NOD Mice as a Model
CD8, and B220 were detected using biotinylated antibodies (Ab)
for IDDM in NOD Mice (Pharmingen, San Diego, CA) followed by phosphatase streptavidin
In NOD mice, some b cell apoptosis precedes infiltration and either BCIP/NBT substrate or HistoMark RED (Kirkegaard and
of the islets by the first DC/Mφ, which secrete high Perry Laboratories, Gaithersburg, MA). CD4 molecules were de-
tected with unlabeled anti-CD4 (GK1.5) Ab followed by an HRP-levels of TNFa in situ (DahleÂ n et al., 1998). CD41 T cells
labeled anti-rat Ab (Southern Biotechnology, Inc., Birmingham, AL)and B cells enter next, with CD81 T cells infiltrating last.
and 3,39-diaminobenzidine tetrahydrochloride (DAB) substrate kitThis nondestructive infiltration occurs between 3±15
(Zymed).
weeks (phase one). A second, as yet unknown trigger Apoptosis was detected in situ in 5±7 mm frozen sections using
between 12±30 weeks (phase two), results in a switch an ApopTag kit (Oncor, Gaithersburg, MD), following the manufac-
from protective Th2 type responses to autoaggressive turer's guidelines.
Sections were stained with the MHC class II1 peptide Ab Y-AETh1 type responses, followed by destruction of the b
using peroxidase followed by the tiramide enhancer Renaissancecells (Sarukhan et al., 1998; reviewed by Delovitch and
(NEN, Boston, MA) and diaminobenzidine as above, shown in red-Singh, 1997). In TNFa-NOD mice, b cell apoptosis pre-
dish brown. Sections were counterstained with neutral red.
cedes insulitis, and DC influx (d10±d21; phase I) insulitis
is followed, after a delay, by destruction of b cells (be- Measurement of Anti-GAD T Cell Activity
tween d42±d70; phase II). There are striking similarities Splenocytes were isolated by crushing spleens through nylon mesh,
and red blood cells were removed with Tris-buffered NH4Cl. Thein the disease process between NOD and TNFa-NOD
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cells were resuspended in RPMI medium supplemented with 5% (1997). Inflammatory stimuli induce accumulation of MHC class II
complexes on dendritic cells. Nature 388, 782±787.fetal bovine serum (RPMI/5) and plated at 5 3 105 cells/well. Freshly
prepared glutamic acid decarboxylase (GAD; provided by Dr. R. Cetkovic-Cvrlje, M., and Eizirik, D.L. (1994). TNF-alpha and IFN-
Sherwin, Yale University, CT) was added as indicated. Following gamma potentiate the deleterious effects of IL-1 beta on mouse
incubation at 378C, 5% CO2 for 4 days, and a 14 hr pulse with 1 mCi/ pancreatic islets mainly via generation of nitric oxide. Cytokine 6,
well [3H]-thymidine (Amersham Pharmacia Biotech Inc., Piscataway, 399±406.
NJ) on the last day of culture, cells were harvested and [3H]-thymi- Chakrabarti, D., Hultgren, B., and Stewart, T.A. (1996). IFN-a induces
dine incorporation measured. autoimmune T cells through the induction of intracellular adhesion
molecule-1 and B7-2. J. Immunol. 157, 522±528.
Isolation of Cells and Cell Sorting Chervonsky, A.V., Wand, Y., Wong, F.S., Visintin, I., Flavell, R.A.,
Islets and pancreatic lymph node (LN) cells were isolated following Janeway, C.A., Jr., and Matis, L.A. (1997). The role of Fas in autoim-
collagenase (Boehringer Mannheim Corp., Indianapolis, IN) diges- mune diabetes. Cell 89, 17±24.
tion of pancreata. Cells within the islets were liberated by trypsiniza-
Cleveland, J.L., and Ihle, J.N. (1995). Contenders in FasL/TNF deathtion and either used in antigen presentation (APC) assays described
signaling. Cell 81, 479±482.below, or sorted into B cell and DC/Mφ populations then used in
Cope, A.P., Liblau, R.S., Yang, X.-D., Congia, M., Laudanna, C.,APC assays. In this latter case, cells were incubated with fluroscein
Schreiber, R.D., Probert, L., Kollias, G., and McDevitt, H.O. (1997).isothiocynate (FITC)-labeled anti-CD45 and phycoerythrin-labeled
Chronic tumor necrosis factor alters T cell responses by attenuatingB220 Abs (Pharmingen), and the CD451/B2201 population (enriched
T cell receptor signaling. J. Exp. Med. 185, 1573±1584.B cells) and CD451/B2202 population (enriched DC/Mφ) were col-
lected using FACStarplus (Becton Dickinson, San Jose, CA). Corcione, A., Ottonella, L., Tortolina, G., Tasso, P., Ghiotto, F., Air-
oldi, I., Taborelli, G., Malavasi, F., Dalledgri, F., and Pistoia, V. (1997).
Recombinant tumour necrosis factor enhances the locomotion ofPurification of CD41 T Cells and APC Assays
memory and naive B lymphocytes from human tonsils through theResponder CD41 T cells were purified from splenocytes using an
selective engagement of the type II receptor. Blood 90, 4493±4501.IsoCell Mouse CD4 Isolation Kit (Pierce Chemical Co., Rockford, IL)
and incubated at 378C, 5% CO2 on plastic for 1 hr to remove re- DahleÂ n, E., Dawe, K., Ohlsson, L., and Hedlund, G. (1998). Dendritic
maining DC/Mφ. Purity of the CD41 T cells was confirmed by FACS. cells and macrophages are the first and major producers of TNFa
All APC sources above were either irradiated (4000 rads for un- in pancreatic islets in the nonobese diabetic mouse. J. Immunol.
sorted islet-derived cells, 3000 rads for enriched DC/Mφ popula- 160, 3585±3593.
tions and lymph node±derived cells) or mitomycin c treated (Sigma Delovitch, T.L., and Singh, B. (1997). The nonobese diabetic mouse
Chemical Co., St. Louis, MO; B220 enriched population). The APC as a model of autoimmune diabetes: immune dysregulation gets
were cultured in RPMI/5 in numbers described in the text with 105 the NOD. Immunity 7, 727±738.
purified CD41 T cells derived from either 6-week-old NOD mice
Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengart-
or the islet-specific TcR, BDC2.5 (Katz et al., 1993b). Cells were
ner, H., Zinkernagel, R., and Pircher, H. (1998). Viral and bacterial
incubated for 4 days, pulsed, and harvested as described above.
infections interfere with peripheral tolerance induction and activate
CD81 T cells to cause immunopathology. J. Exp. Med. 5, 763±774.
Diabetes Detection
Ettinger, R., Cope, A., van Ewijk, W., and McDevitt, H.O. (1998).
Mice were tested weekly for glycosuria using Diastix reagent strips
Effects of neonatal TNF and anti-TNF treatment of NOD mice on
(Ames, Elkhart, IN). Diabetes was confirmed when nonfasting glu-
central and peripheral lymphoid development. FASEB J. 12, A6354.
cose values in the serum were determined to be higher than 250
Gonzalez, A., Katz, J.D., Mattei, M.-G., Kikutani, H., Benoist, C., andmg/dl for 2 days using One Touch test strips (Lifescan Inc., Johnson
Mathis, D. (1997). Genetic control of diabetes progression. Immunityand Johnson Co., Milpitas, CA).
7, 873±883.
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